In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.

被引:44
作者
Cordoba, Susana [1 ]
Rodero, Laura [2 ]
Vivot, Walter [1 ]
Abrantes, Ruben [1 ]
Davel, Graciela [1 ]
Vitale, Roxana G. [1 ,3 ,4 ]
机构
[1] ANLIS Dr CG Malbran, INEI, Dept Micol, Buenos Aires, DF, Argentina
[2] Univ Catol, Fac Ciencias Med, Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina
[4] Centraalbureau Voor Schimmelcultures, Utrecht, Netherlands
关键词
Fusarium spp; antifungal susceptibility; antifungal interactions;
D O I
10.1016/j.ijantimicag.2007.09.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activities of amphotericin B (AMB), itraconazole (ITC), voriconazole (VCZ) and terbinafine (TBF) alone and in the combinations AMB + VCZ, TBF + ITC and TBF + VCZ were evaluated against 29 clinical isolates of Fusarium spp. (15 Fusarium solani, 7 Fusarium oxysporum, 2 Fusarium decemcellulare, 2 Fusarium dimerum and 3 other Fusarium spp.). Minimum inhibitory concentrations were determined using the method of the Clinical and Laboratory Standards Institute and the interaction activity was calculated using the fractional inhibitory concentration index. The four antifungal drugs tested alone showed very limited activity against most of the isolates. In contrast., the combination TBF + VCZ showed synergy for 21 isolates. The combination AMB + VCZ showed synergism for only five strains. No interaction or antagonism was observed among the remaining strains. TBF + ITC showed no interaction for 18 strains. The in vitro antifungal activity of the drugs alone and in combination varied for different species. These results corroborate previous in vitro studies in which the combination TBF + VCZ showed synergy against Fusarium spp., although further studies are needed to elucidate its potential usefulness for therapy. (C) 2007 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:171 / 174
页数:4
相关论文
共 18 条
  • [1] [Anonymous], CLIN MYCOLOGY
  • [2] Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Nangia, S
    Rex, JH
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) : 3946 - 3951
  • [3] Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management
    Boutati, EI
    Anaissie, EJ
    [J]. BLOOD, 1997, 90 (03) : 999 - 1008
  • [4] Human fusariosis
    Dignani, MC
    Anaissie, E
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 : 67 - 75
  • [5] Successful outcome of disseminated Fusatium infection with skin localization treated with voriconazole and amphotericin B-Lipid complex in a patient with acute leukemia
    Durand-Joly, I
    Alfandari, S
    Benchikh, Z
    Rodrigue, M
    Espinel-Ingroff, A
    Catteau, B
    Cordevant, C
    Camus, D
    Dei-Cas, E
    Bauters, F
    Delhaes, L
    De Botton, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) : 4898 - 4900
  • [6] Preface - Fungal infections, - Part I - Recent advances in diagnosis, treatment, and prevention of opportunistic mycoses
    Walsh, TJ
    Rex, JH
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (04) : IX - X
  • [7] Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance
    Ghannoum, MA
    Rice, LB
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (04) : 501 - +
  • [8] Antifungal pharmacodynamics: Concentration-effect relationships in vitro and in vivo
    Groll, AH
    Piscitelli, SC
    Walsh, TJ
    [J]. PHARMACOTHERAPY, 2001, 21 (08): : 133S - 148S
  • [9] Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report
    Manuel Vagace, Jose
    Sanz-Rodriguez, Cesar
    Casado, Maria-Soledad
    Alonso, Nieves
    Garcia-Dominguez, Manuel
    Garcia de la Llana, Francisco
    Zarallo, Luis
    Fajardo, Miguel
    Bajo, Roberto
    [J]. BMC INFECTIOUS DISEASES, 2007, 7 (1)
  • [10] MARGALITH PZ, 1986, STEROID MICROBIOLOGY